Winterich, J. (August 2008). "Gender, medicine, and the menopausal body: How biology and culture influence women's experiences with menopause". Paper presented at the annual meeting of the American Sociological Association, New York. Retrieved 11 November 2008 from Allacademic.com互联网档案馆的存檔,存档日期9 July 2012.
Krause, MS; Nakajima, ST. Hormonal and Nonhormonal Treatment of Vasomotor Symptoms.. Obstetrics and Gynecology Clinics of North America. March 2015, 42 (1): 163–179. PMID 25681847. doi:10.1016/j.ogc.2014.09.008.
Dreisler, E; Poulsen, LG; Antonsen, SL; Ceausu, I; Depypere, H; Erel, CT; Lambrinoudaki, I; Pérez-López, FR; Simoncini, T; Tremollieres, F; Rees, M; Ulrich, LG. EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women. Maturitas. 2013, 75 (2): 181–90. PMID 23619009. doi:10.1016/j.maturitas.2013.03.011.
Pérez-López, FR; Cuadros, JL; Fernández-Alonso, AM; Chedraui, P; Sánchez-Borrego, R; Monterrosa-Castro, A. Quality of life in a large cohort of mid-aged Colombian women assessed using the Cervantes Scale. Maturitas. 2012, 73 (4): 369–72. PMID 23041251. doi:10.1016/j.maturitas.2012.09.004.
Chedraui, P; Pérez-López, FR; Mendoza, M; Leimberg, ML; Martínez, MA; Vallarino, V; Hidalgo, L. Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth sleepiness scale. Maturitas. 2010, 65 (1): 75–80. PMID 19945237. doi:10.1016/j.maturitas.2009.11.003.
Arakane, M; Castillo, C; Rosero, MF; Peñafiel, R; Pérez-López, FR; Chedraui, P. Factors relating to insomnia during the menopausal transition as evaluated by the Insomnia Severity Index.. Maturitas. 2011, 69 (2): 157–61. PMID 21444163. doi:10.1016/j.maturitas.2011.02.015.
Monterrosa-Castro, A; Marrugo-Flórez, M; Romero-Pérez, I; Chedraui, P; Fernández-Alonso, AM; Pérez-López, FR. Prevalence of insomnia and related factors in a large mid-aged female Colombian sample. Maturitas. 2013, 74 (4): 346–51. PMID 23391501. doi:10.1016/j.maturitas.2013.01.009.
Souza, Hugo. Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training. Aging and Disease. 2013, 4 (6): 320–28. ISSN 2152-5250. doi:10.14336/AD.2013.0400320.
Triebner, Kai; Matulonga, Bobette; Johannessen, Ane; Suske, Sandra; Benediktsdóttir, Bryndís; Demoly, Pascal; Dharmage, Shyamali C.; Franklin, Karl A.; Garcia Aymerich, Judith. Menopause is Associated with Accelerated Lung Function Decline. American Journal of Respiratory and Critical Care Medicine. 2016-12-01. ISSN 1535-4970. PMID 27907454. doi:10.1164/rccm.201605-0968OC.
Muka, Taulant; Oliver-Williams, Clare; Kunutsor, Setor; Laven, Joop S. E.; Fauser, Bart C. J. M.; Chowdhury, Rajiv; Kavousi, Maryam; Franco, Oscar H. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality. JAMA Cardiology. 14 September 2016, 1: 767. doi:10.1001/jamacardio.2016.2415.
Monterrosa-Castro, A; Romero-Pérez, I; Marrugo-Flórez, M; Fernández-Alonso, AM; Chedraui, P; Pérez-López, FR. Quality of life in a large cohort of mid-aged Colombian women assessed using the Cervantes Scale. Menopause. 2012, 19 (8): 924–30. PMID 22549166. doi:10.1097/gme.0b013e318247908d.
McNamara, M; Batur, P; DeSapri, KT. In the clinic. Perimenopause.. Annals of Internal Medicine. 3 February 2015, 162 (3): ITC1–15. PMID 25643316. doi:10.7326/AITC201502030.
Bellipanni, G; Di Marzo, F; Blasi, F; Di Marzo, A. Effects of melatonin in perimenopausal and menopausal women: our personal experience. 2005. Annals of the New York Academy of Sciences. 2005-12, 1057 (1): 393–402. PMID 16399909. doi:10.1196/annals.1356.030.
Prior, JC. Perimenopause: The Complex Endocrinology of the Menopausal Transition. Endocrine Reviews: 397–428. doi:10.1210/edrv.19.4.0341.
Burger, HG. Diagnostic role of follicle stimulating hormone (FSH) measurements during menopausal transition – an analysis of FSH, oestradiol and inhibin. European Journal of Endocrinology. 1994, 130 (1): 38–42. PMID 8124478. doi:10.1530/eje.0.1300038.
Nahás E, Pontes A, Traiman P, NahásNeto J, Dalben I, De Luca L. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol. Endocrinol. 2003, 17: 125–31. PMID 12737673. doi:10.1080/713603218.
Burger, HG. Diagnostic role of follicle stimulating hormone (FSH) measurements during menopausal transition – an analysis of FSH, oestraiol and inhibin. European Journal of Endocrinology. 1994, 130 (1): 38–42. PMID 8124478. doi:10.1530/eje.0.1300038.
Simpson, ER; Davis, SR. Minireview: aromatase and the regulation of estrogen biosynthesis – some new perspectives. Endocrinology. 2001, 142 (11): 4589–94. PMID 11606422. doi:10.1210/en.142.11.4589.
Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause (New York, N.Y.). Mar 2010, 17 (2): 242–55. PMID 20154637. doi:10.1097/gme.0b013e3181d0f6b9.
The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. July 2017, 24 (7): 728–753. doi:10.1097/GME.0000000000000921.
Boardman, Henry M. P.; Hartley, Louise; Eisinga, Anne; Main, Caroline; Roqué i Figuls, Marta; Bonfill Cosp, Xavier; Gabriel Sanchez, Rafael; Knight, Beatrice. Hormone therapy for preventing cardiovascular disease in post-menopausal women. The Cochrane Database of Systematic Reviews. 2015-03-10, (3): CD002229. ISSN 1469-493X. PMID 25754617. doi:10.1002/14651858.CD002229.pub4.
de Villiers, TJ; Stevenson, JC. The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric. June 2012, 15 (3): 263–66. PMID 22612613. doi:10.3109/13697137.2012.659975.
Marjoribanks, Jane; Farquhar, Cindy; Roberts, Helen; Lethaby, Anne; Lee, Jasmine. Long-term hormone therapy for perimenopausal and postmenopausal women. The Cochrane Database of Systematic Reviews. 17 Jan 2017, 1: CD004143. ISSN 1469-493X. PMID 28093732. doi:10.1002/14651858.CD004143.pub5.
Chlebowski, R. T.; Anderson, G. L. Menopausal hormone therapy and breast cancer mortality: clinical implications. Therapeutic Advances in Drug Safety. 2015, 6 (2): 45–56. ISSN 2042-0986. doi:10.1177/2042098614568300.
Davis, SR; Dinatale, I; Rivera-Woll, L; Davison, S. Postmenopausal hormone therapy: from monkey glands to transdermal patches. J Endocrinol. 2005, 185 (2): 207–22. PMID 15845914. doi:10.1677/joe.1.05847.
Orleans, RJ; Li, L; Kim, MJ; Guo, J; Sobhan, M; Soule, L; Joffe, HV. FDA approval of paroxetine for menopausal hot flushes. The New England Journal of Medicine. 2014, 370 (19): 1777–79. PMID 24806158. doi:10.1056/NEJMp1402080.
Nedrow, A; Miller, J; Walker, M; Nygren, P; Huffman, LH; Nelson, HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med. 2006, 166 (14): 1453–65. doi:10.1001/archinte.166.14.1453.
Franco, Oscar H.; Chowdhury, Rajiv; Troup, Jenna; Voortman, Trudy; Kunutsor, Setor; Kavousi, Maryam; Oliver-Williams, Clare; Muka, Taulant. Use of Plant-Based Therapies and Menopausal Symptoms. JAMA. 21 June 2016, 315 (23): 2554–63. PMID 27327802. doi:10.1001/jama.2016.8012.
Bolaños, R; Del Castillo, A; Francia, J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis.. Menopause. 2010, 17 (3): 660–66. PMID 20464785. doi:10.1097/gme.0b013e3181cb4fb5.
Lethaby, A; Marjoribanks, J; Kronenberg, F; Roberts, H; Eden, J; Brown, J. Phytoestrogens for menopausal vasomotor symptoms.. Cochrane Database of Systematic Reviews. 10 December 2013, 12: CD001395. PMID 24323914. doi:10.1002/14651858.CD001395.pub4.
Leach, MJ; Moore, V. Black cohosh (Cimicifuga spp.) for menopausal symptoms.. Cochrane Database of Systematic Reviews. 12 September 2012, 9: CD007244. PMID 22972105. doi:10.1002/14651858.CD007244.pub2.
Clement, YN; Onakpoya, I; Hung, SK; Ernst, E. Effects of herbal and dietary supplements on cognition in menopause: a systematic review.. Maturitas. March 2011, 68 (3): 256–63. PMID 21237589. doi:10.1016/j.maturitas.2010.12.005.
Dodin, S; Blanchet, C; Marc, I; Ernst, E; Wu, T; Vaillancourt, C; Paquette, J; Maunsell, E. Acupuncture for menopausal hot flushes.. Cochrane Database of Systematic Reviews. 30 July 2013, 7: CD007410. PMID 23897589. doi:10.1002/14651858.CD007410.pub2.
Wells, GA; Cranney, A; Peterson, J; Boucher, M; Shea, B; Robinson, V; Coyle, D; Tugwell, P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews. Jan 23, 2008, (1): CD001155. PMID 18253985. doi:10.1002/14651858.CD001155.pub2.
Gold, EB; Block, G; Crawford, S; Lachance, L; FitzGerald, G; Miracle, H; Sherman, S. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology. 2004, 159 (12): 1189–99. PMID 15191936. doi:10.1093/aje/kwh168.
Maoz, B.; Dowty, N.; Antonovsky, A.; Wisjenbeck, H. Female attitudes to menopause. Social Psychiatry. 1970, 5: 35–40. doi:10.1007/BF01539794.
Stotland, N. L. Menopause: Social expectations, women's realities. Archives of Women's Mental Health. 2002, 5: 5–8. doi:10.1007/s007370200016.
EFSA Femarelle® and bone mineral density (页面存档备份,存于互联网档案馆) Scientific substantiation of a health claim related to "Femarelle®" and "induces bone formation and increases bone mineral density reducing the risk for osteoporosis and other bone disorders" pursuant to Article 14 of the Regulation (EC) No 1924/20061 Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. The EFSA Journal (2008) 785, pp. 1–10]
Krause, MS; Nakajima, ST. Hormonal and Nonhormonal Treatment of Vasomotor Symptoms.. Obstetrics and Gynecology Clinics of North America. March 2015, 42 (1): 163–179. PMID 25681847. doi:10.1016/j.ogc.2014.09.008.
Menopause: Overview. PubMedHealth. 29 August 2013 [8 March 2015]. (原始内容存档于2017-09-10).
Dreisler, E; Poulsen, LG; Antonsen, SL; Ceausu, I; Depypere, H; Erel, CT; Lambrinoudaki, I; Pérez-López, FR; Simoncini, T; Tremollieres, F; Rees, M; Ulrich, LG. EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women. Maturitas. 2013, 75 (2): 181–90. PMID 23619009. doi:10.1016/j.maturitas.2013.03.011.
Pérez-López, FR; Cuadros, JL; Fernández-Alonso, AM; Chedraui, P; Sánchez-Borrego, R; Monterrosa-Castro, A. Quality of life in a large cohort of mid-aged Colombian women assessed using the Cervantes Scale. Maturitas. 2012, 73 (4): 369–72. PMID 23041251. doi:10.1016/j.maturitas.2012.09.004.
Chedraui, P; Pérez-López, FR; Mendoza, M; Leimberg, ML; Martínez, MA; Vallarino, V; Hidalgo, L. Factors related to increased daytime sleepiness during the menopausal transition as evaluated by the Epworth sleepiness scale. Maturitas. 2010, 65 (1): 75–80. PMID 19945237. doi:10.1016/j.maturitas.2009.11.003.
Arakane, M; Castillo, C; Rosero, MF; Peñafiel, R; Pérez-López, FR; Chedraui, P. Factors relating to insomnia during the menopausal transition as evaluated by the Insomnia Severity Index.. Maturitas. 2011, 69 (2): 157–61. PMID 21444163. doi:10.1016/j.maturitas.2011.02.015.
Monterrosa-Castro, A; Marrugo-Flórez, M; Romero-Pérez, I; Chedraui, P; Fernández-Alonso, AM; Pérez-López, FR. Prevalence of insomnia and related factors in a large mid-aged female Colombian sample. Maturitas. 2013, 74 (4): 346–51. PMID 23391501. doi:10.1016/j.maturitas.2013.01.009.
Monterrosa-Castro, A; Romero-Pérez, I; Marrugo-Flórez, M; Fernández-Alonso, AM; Chedraui, P; Pérez-López, FR. Quality of life in a large cohort of mid-aged Colombian women assessed using the Cervantes Scale. Menopause. 2012, 19 (8): 924–30. PMID 22549166. doi:10.1097/gme.0b013e318247908d.
McNamara, M; Batur, P; DeSapri, KT. In the clinic. Perimenopause.. Annals of Internal Medicine. 3 February 2015, 162 (3): ITC1–15. PMID 25643316. doi:10.7326/AITC201502030.
Bellipanni, G; Di Marzo, F; Blasi, F; Di Marzo, A. Effects of melatonin in perimenopausal and menopausal women: our personal experience. 2005. Annals of the New York Academy of Sciences. 2005-12, 1057 (1): 393–402. PMID 16399909. doi:10.1196/annals.1356.030.
Burger, HG. Diagnostic role of follicle stimulating hormone (FSH) measurements during menopausal transition – an analysis of FSH, oestradiol and inhibin. European Journal of Endocrinology. 1994, 130 (1): 38–42. PMID 8124478. doi:10.1530/eje.0.1300038.
Nahás E, Pontes A, Traiman P, NahásNeto J, Dalben I, De Luca L. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol. Endocrinol. 2003, 17: 125–31. PMID 12737673. doi:10.1080/713603218.
Burger, HG. Diagnostic role of follicle stimulating hormone (FSH) measurements during menopausal transition – an analysis of FSH, oestraiol and inhibin. European Journal of Endocrinology. 1994, 130 (1): 38–42. PMID 8124478. doi:10.1530/eje.0.1300038.
Simpson, ER; Davis, SR. Minireview: aromatase and the regulation of estrogen biosynthesis – some new perspectives. Endocrinology. 2001, 142 (11): 4589–94. PMID 11606422. doi:10.1210/en.142.11.4589.
Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause (New York, N.Y.). Mar 2010, 17 (2): 242–55. PMID 20154637. doi:10.1097/gme.0b013e3181d0f6b9.
Boardman, Henry M. P.; Hartley, Louise; Eisinga, Anne; Main, Caroline; Roqué i Figuls, Marta; Bonfill Cosp, Xavier; Gabriel Sanchez, Rafael; Knight, Beatrice. Hormone therapy for preventing cardiovascular disease in post-menopausal women. The Cochrane Database of Systematic Reviews. 2015-03-10, (3): CD002229. ISSN 1469-493X. PMID 25754617. doi:10.1002/14651858.CD002229.pub4.
de Villiers, TJ; Stevenson, JC. The WHI: the effect of hormone replacement therapy on fracture prevention. Climacteric. June 2012, 15 (3): 263–66. PMID 22612613. doi:10.3109/13697137.2012.659975.
Marjoribanks, Jane; Farquhar, Cindy; Roberts, Helen; Lethaby, Anne; Lee, Jasmine. Long-term hormone therapy for perimenopausal and postmenopausal women. The Cochrane Database of Systematic Reviews. 17 Jan 2017, 1: CD004143. ISSN 1469-493X. PMID 28093732. doi:10.1002/14651858.CD004143.pub5.
Davis, SR; Dinatale, I; Rivera-Woll, L; Davison, S. Postmenopausal hormone therapy: from monkey glands to transdermal patches. J Endocrinol. 2005, 185 (2): 207–22. PMID 15845914. doi:10.1677/joe.1.05847.
Orleans, RJ; Li, L; Kim, MJ; Guo, J; Sobhan, M; Soule, L; Joffe, HV. FDA approval of paroxetine for menopausal hot flushes. The New England Journal of Medicine. 2014, 370 (19): 1777–79. PMID 24806158. doi:10.1056/NEJMp1402080.
Franco, Oscar H.; Chowdhury, Rajiv; Troup, Jenna; Voortman, Trudy; Kunutsor, Setor; Kavousi, Maryam; Oliver-Williams, Clare; Muka, Taulant. Use of Plant-Based Therapies and Menopausal Symptoms. JAMA. 21 June 2016, 315 (23): 2554–63. PMID 27327802. doi:10.1001/jama.2016.8012.
Bolaños, R; Del Castillo, A; Francia, J. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis.. Menopause. 2010, 17 (3): 660–66. PMID 20464785. doi:10.1097/gme.0b013e3181cb4fb5.
Lethaby, A; Marjoribanks, J; Kronenberg, F; Roberts, H; Eden, J; Brown, J. Phytoestrogens for menopausal vasomotor symptoms.. Cochrane Database of Systematic Reviews. 10 December 2013, 12: CD001395. PMID 24323914. doi:10.1002/14651858.CD001395.pub4.
Leach, MJ; Moore, V. Black cohosh (Cimicifuga spp.) for menopausal symptoms.. Cochrane Database of Systematic Reviews. 12 September 2012, 9: CD007244. PMID 22972105. doi:10.1002/14651858.CD007244.pub2.
Clement, YN; Onakpoya, I; Hung, SK; Ernst, E. Effects of herbal and dietary supplements on cognition in menopause: a systematic review.. Maturitas. March 2011, 68 (3): 256–63. PMID 21237589. doi:10.1016/j.maturitas.2010.12.005.
Dodin, S; Blanchet, C; Marc, I; Ernst, E; Wu, T; Vaillancourt, C; Paquette, J; Maunsell, E. Acupuncture for menopausal hot flushes.. Cochrane Database of Systematic Reviews. 30 July 2013, 7: CD007410. PMID 23897589. doi:10.1002/14651858.CD007410.pub2.
Wells, GA; Cranney, A; Peterson, J; Boucher, M; Shea, B; Robinson, V; Coyle, D; Tugwell, P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database of Systematic Reviews. Jan 23, 2008, (1): CD001155. PMID 18253985. doi:10.1002/14651858.CD001155.pub2.
Gold, EB; Block, G; Crawford, S; Lachance, L; FitzGerald, G; Miracle, H; Sherman, S. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology. 2004, 159 (12): 1189–99. PMID 15191936. doi:10.1093/aje/kwh168.
Menopause: Overview. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 2013-06-28 [8 March 2015]. (原始内容存档于2015-04-02).
What is menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 2013-06-28 [8 March 2015]. (原始内容存档于2015-03-19).
What causes menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-04-02).
What are the symptoms of menopause. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-03-20).
What causes menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-04-02).
Menopause: Overview. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 2013-06-28 [8 March 2015]. (原始内容存档于2015-04-02).
What is menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 2013-06-28 [8 March 2015]. (原始内容存档于2015-03-19).
What causes menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-04-02).
What are the symptoms of menopause. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-03-20).
What causes menopause?. Eunice Kennedy Shriver National Institute of Child Health and Human Development. 6 May 2013 [8 March 2015]. (原始内容存档于2015-04-02).
EFSA Femarelle® and bone mineral density (页面存档备份,存于互联网档案馆) Scientific substantiation of a health claim related to "Femarelle®" and "induces bone formation and increases bone mineral density reducing the risk for osteoporosis and other bone disorders" pursuant to Article 14 of the Regulation (EC) No 1924/20061 Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies. The EFSA Journal (2008) 785, pp. 1–10]
Winterich, J. (August 2008). "Gender, medicine, and the menopausal body: How biology and culture influence women's experiences with menopause". Paper presented at the annual meeting of the American Sociological Association, New York. Retrieved 11 November 2008 from Allacademic.com互联网档案馆的存檔,存档日期9 July 2012.
Souza, Hugo. Autonomic Cardiovascular Damage during Post-menopause: the Role of Physical Training. Aging and Disease. 2013, 4 (6): 320–28. ISSN 2152-5250. doi:10.14336/AD.2013.0400320.
Triebner, Kai; Matulonga, Bobette; Johannessen, Ane; Suske, Sandra; Benediktsdóttir, Bryndís; Demoly, Pascal; Dharmage, Shyamali C.; Franklin, Karl A.; Garcia Aymerich, Judith. Menopause is Associated with Accelerated Lung Function Decline. American Journal of Respiratory and Critical Care Medicine. 2016-12-01. ISSN 1535-4970. PMID 27907454. doi:10.1164/rccm.201605-0968OC.
Boardman, Henry M. P.; Hartley, Louise; Eisinga, Anne; Main, Caroline; Roqué i Figuls, Marta; Bonfill Cosp, Xavier; Gabriel Sanchez, Rafael; Knight, Beatrice. Hormone therapy for preventing cardiovascular disease in post-menopausal women. The Cochrane Database of Systematic Reviews. 2015-03-10, (3): CD002229. ISSN 1469-493X. PMID 25754617. doi:10.1002/14651858.CD002229.pub4.
Marjoribanks, Jane; Farquhar, Cindy; Roberts, Helen; Lethaby, Anne; Lee, Jasmine. Long-term hormone therapy for perimenopausal and postmenopausal women. The Cochrane Database of Systematic Reviews. 17 Jan 2017, 1: CD004143. ISSN 1469-493X. PMID 28093732. doi:10.1002/14651858.CD004143.pub5.
Chlebowski, R. T.; Anderson, G. L. Menopausal hormone therapy and breast cancer mortality: clinical implications. Therapeutic Advances in Drug Safety. 2015, 6 (2): 45–56. ISSN 2042-0986. doi:10.1177/2042098614568300.